Blue Latitude handed extended European contract with Janssen

Blue Latitude has won a renewed three-year contract with pharmaceutical company Janssen in the Europe, Middle East and Africa (EMEA) region.

Following a successful partnership, Janssen has reappointed Blue Latitude to provide strategic marketing support and services to the company's EMEA brand teams, with the work to span a wide range of therapy areas.

The agency won this new contract after having demonstrated a solid knowledge of Janssen's marketing needs, while the firm was also praised for its strategic thinking, energy and creativity.

Janssen develops therapies in a diverse range of therapy areas including oncology, immunology, neuroscience, infectious disease, and cardiovascular and metabolic diseases.

Martin Brass, co-founder and managing director at Blue Latitude, said: "We are absolutely thrilled to extend our partnership with Janssen to include their brand teams in the EMEA region and start offering our full range of strategic marketing services."

The agency has experienced significant growth in 2015, having hired 11 people so far this year.